Ferritin level changes and erythroid improvement in a group of adult polytransfused patients treated with Deferasirox

BACKGROUND AND AIMS: Chelating agents therapy is recommended for polytransfused patients that have evidence of iron overload (an elevated serum ferritin or received over 20 units of red blood cell transfusions). Deferasirox showed efficacy and safety in maintaining or reducing body iron. Iron chelat...

Descripción completa

Detalles Bibliográficos
Autores principales: PARVU, ANDRADA VIORICA, BOJAN, ANCA, URIAN, LAURA, TOROK, TUNDE, ZSOLDOS, IULIA ANDREA, IANCU, MIHAELA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082613/
https://www.ncbi.nlm.nih.gov/pubmed/30093806
http://dx.doi.org/10.15386/cjmed-942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082613/
https://www.ncbi.nlm.nih.gov/pubmed/30093806
http://dx.doi.org/10.15386/cjmed-942

Ejemplares similares